SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-024327
Filing Date
2024-05-03
Accepted
2024-05-03 16:05:33
Documents
13
Period of Report
2024-05-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20028422_8k.htm   iXBRL 8-K 53504
  Complete submission text file 0001140361-24-024327.txt   189282

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vcel-20240501.xsd EX-101.SCH 3856
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcel-20240501_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcel-20240501_pre.xml EX-101.PRE 16038
16 EXTRACTED XBRL INSTANCE DOCUMENT ef20028422_8k_htm.xml XML 4044
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

IRS No.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35280 | Film No.: 24912984
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)